The stock boasts the one year return of 34.3%, in contrast to 16.4% for the S&P 500. This situation necessitates a ...

Hims & Hers Health, Inc. is rated a Buy with strong subscriber growth and rising revenue per subscriber. Learn more about ...

Dudum said individuals are taking greater control of care through DTC access, preventive health, and wider use of AI. ・BofA ...

Hims & Hers is achieving tremendous revenue growth with a renewed Novo Nordisk weight loss partnership. Click here to read an ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 4% Friday after Amazon (NASDAQ:AMZN) Pharmacy announced it would ...

A coalition of telehealth providers from Amazon and Hims & Hers to hospital systems is working to extend pandemic-era waivers ...

This post is brought to you in paid partnership with Hims. We’re one week into the new year. By now, the initial burst of ...

Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty ...

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo ...

A short squeeze occurs when a stock's price rises unexpectedly, forcing short sellers (who are now losing money) to ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...